0001562180-18-003433.txt : 20180731 0001562180-18-003433.hdr.sgml : 20180731 20180731165701 ACCESSION NUMBER: 0001562180-18-003433 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180730 FILED AS OF DATE: 20180731 DATE AS OF CHANGE: 20180731 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haddock Jason CENTRAL INDEX KEY: 0001680628 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 18981825 MAIL ADDRESS: STREET 1: C/O ARRAY BIOPHARMA INC., 3200 WALNUT ST CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-07-30 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001680628 Haddock Jason C/O ARRAY BIOPHARMA, 3200 WALNUT ST BOULDER CO 80301 false true false false CFO Common Stock 2018-07-30 4 M false 51525.00 3.77 A 80393.00 D Common Stock 2018-07-30 4 S false 25000.00 14.87 D 55393.00 D Stock Option (Right to Buy) 3.77 2018-07-30 4 M false 51525.00 0.00 D 2026-07-28 Common Stock 51525.00 489450.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. The price reported for these shares is the weighted average sale price of transactions made at prices from $14.70 to $15.10. Details of actual prices for shares sold are available from the Issuer upon request. The options vest in four equal annual installments beginning on July 28, 2017. Jason Haddock 2018-07-31